HBIO vs MRO
Harvard Bioscience Inc (HBIO) versus MRO (MRO) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
MRO (MRO) common stock.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
MRO does not have a complete income-statement cache yet.
HBIO currently screens at market cap $20.3M.
Not investment advice. Open the HBIO and MRO stock pages for the full models.
Not investment advice.